Design of Orally-bioavailable Tetra-cyclic phthalazine SOS1 inhibitors with high selectivity against EGFR
Bioorganic Chemistry · 2023
DOI: 10.1016/j.bioorg.2023.106536 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2023. Verfasst von Huan He und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Guizhou University, Guiyang 550025, PR China; Key Laboratory of Coal Conversion and New Carbon Materials of Hubei …. Hauptthemen laut MEDLINE: SOS1 Protein, Proto-Oncogene Proteins p21(ras). Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Tianjin Science and Technology Committee, National Natural Science Foundation of China.
Abstract (Originalsprache)
KRAS mutations (G12C, G12D, etc.) are implicated in the oncogenesis and progression of many deadliest cancers. Son of sevenless homolog 1 (SOS1) is a crucial regulator of KRAS to modulate KRAS from inactive to active states. We previously discovered tetra-cyclic quinazolines as an improved scaffold for inhibiting SOS1-KRAS interaction. In this work, we report the design of tetra-cyclic phthalazine derivatives for selectively inhibiting SOS1 against EGFR. The lead compound 6c displayed remarkable activity to inhibit the proliferation of KRAS(G12C)-mutant pancreas cells. 6c showed a favorable pharmacokinetic profile in vivo, with a bioavailability of 65.8% and exhibited potent tumor suppression in pancreas tumor xenograft models. These intriguing results suggested that 6c has the potential to be developed as a drug candidate for KRAS-driven tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Guizhou University, Guiyang 550025, PR China; Key Laboratory of Coal Conversion and New Carbon Materials of Hubei Province, College of Chemistry and Chemical Engineering, Wuhan Univers…
- Key Laboratory of Coal Conversion and New Carbon Materials of Hubei Province, College of Chemistry and Chemical Engineering, Wuhan University of Science and Technology, Wuhan 430081, PR China.
- Key Laboratory of Coal Conversion and New Carbon Materials of Hubei Province, College of Chemistry and Chemical Engineering, Wuhan University of Science and Technology, Wuhan 430081, PR China; School of Chemical and Env…
- School of Pharmaceutical Sciences, Guizhou University, Guiyang 550025, PR China. Electronic address: wdpan@163.com.
- Key Laboratory of Coal Conversion and New Carbon Materials of Hubei Province, College of Chemistry and Chemical Engineering, Wuhan University of Science and Technology, Wuhan 430081, PR China. Electronic address: fang_h…
Förderung
- Tianjin Science and Technology Committee
- National Natural Science Foundation of China
Zitieren
APA
He, H., Chen, R., Wang, Z., Qing, L., Zhang, Y., Liu, Y., Pan, W., Fang, H., & Zhang, S. (2023). Design of Orally-bioavailable Tetra-cyclic phthalazine SOS1 inhibitors with high selectivity against EGFR. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2023.106536
Vancouver
He H, Chen R, Wang Z, Qing L, Zhang Y, Liu Y, et al. Design of Orally-bioavailable Tetra-cyclic phthalazine SOS1 inhibitors with high selectivity against EGFR. Bioorganic Chemistry. 2023. doi:10.1016/j.bioorg.2023.106536
BibTeX
@article{He2023,
author = {He, Huan and Chen, Ruiqi and Wang, Ziwei and Qing, Luolong and Zhang, Yu and Liu, Yi and Pan, Weidong and Fang, Huaxiang and Zhang, Silong},
title = {Design of Orally-bioavailable Tetra-cyclic phthalazine SOS1 inhibitors with high selectivity against EGFR},
journal = {Bioorganic Chemistry},
year = {2023},
doi = {10.1016/j.bioorg.2023.106536}
}
EUVIMED